ALKS stock · DVA stock

ALKS vs DVA

Alkermes Plc (ALKS) versus DaVita HealthCare Partners Inc (DVA) — a side-by-side from cached financials, not a winner call.

Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.

DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.

Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.

Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.

ALKS currently screens at market cap $4.78B and trailing P/E 13.8. DVA currently screens at market cap $10.77B and trailing P/E 14.1.

Not investment advice. Open the ALKS and DVA stock pages for the full models.

Not investment advice.

Popular Stock Comparisons